Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M. Zandvliet. (2016) Canine lymphoma: a review. Veterinary Quarterly 36:2, pages 76-104.
Read now
Read now
Articles from other publishers (36)
Wesley A. Wierson, Alex M. Abel, Elizabeth L. Siegler, Stephen C. Ekker, Chad M. Johannes, Saad S. Kenderian & Jonathan P. Mochel. 2023. Therapeutic Strategies in Veterinary Oncology. Therapeutic Strategies in Veterinary Oncology
155
180
.
Nicola Mason & Steven Dow. 2023. Therapeutic Strategies in Veterinary Oncology. Therapeutic Strategies in Veterinary Oncology
121
154
.
Christopher J. Pinard, Andrew Lagree, Fang-I Lu, Jonathan Klein, Michelle L. Oblak, Roberto Salgado, Juan Carlos Pinto Cardenas, Barbara Brunetti, Luisa Vera Muscatello, Giuseppe Sarli, Maria Pia Foschini, Alexandros Hardas, Simon P. Castillo, Khalid AbdulJabbar, Yinyin Yuan, David A. Moore & William T. Tran. (2022) Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy. Cancers 14:20, pages 5008.
Crossref
Crossref
Sunirmal Sheet, Ye-In Oh, Devender Arora, Bong-Hwan Choi, Minjeong Ko, Yelin Nam, Youngjo Lim, Jin-A Lim, Mirim Park, Woncheoul Park, Kyoung-Won Seo & Kyung-Tai Lee. (2022) Insight into the potential candidate genes and signaling pathways involved in lymphoma disease in dogs using a comprehensive whole blood transcriptome analysis. Gene 838, pages 146735.
Crossref
Crossref
Joana N. R. Dias, André Almeida, Ana S. André, Sandra I. Aguiar, Pedro Bule, Sara Nogueira, Soraia S. Oliveira, Belmira Carrapiço, Solange Gil, Luís Tavares & Frederico Aires-da-Silva. (2022) Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy. Scientific Reports 12:1.
Crossref
Crossref
Ellen E. Sparger, Hong Chang, Ning Chin, Robert B. Rebhun, Sita S. Withers, Hung Kieu, Robert J. Canter, Arta M. Monjazeb & Michael S. Kent. (2021) T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma. Frontiers in Veterinary Science 8.
Crossref
Crossref
Joana N. R. Dias, Ana S. André, Sandra I. Aguiar, Solange Gil, Luís Tavares & Frederico Aires-da-Silva. (2021) Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma. Frontiers in Veterinary Science 8.
Crossref
Crossref
Yuki Morinaga, Masaya Igase, Takuma Yanase, Yusuke Sakai, Hiroki Sakai, Aki Fujiwara-Igarashi, Hajime Tsujimoto, Masaru Okuda & Takuya Mizuno. (2021) Expression of DEP Domain-Containing 1B in Canine Lymphoma and Other Types of Canine Tumours. Journal of Comparative Pathology 185, pages 55-65.
Crossref
Crossref
Fulvio Riondato & Stefano Comazzi. (2021) Flow Cytometry in the Diagnosis of Canine B-Cell Lymphoma. Frontiers in Veterinary Science 8.
Crossref
Crossref
Lukas Uhrik, Lenka Hernychova, Petr Muller, Umesh Kalathiya, Malgorzata M. Lisowska, Mikolaj KocikowskiMaciej ParysJakub Faktor, Marta Nekulova, Chris NortcliffePavlina Zatloukalova, Barbara Ruetgen, Robin Fahraeus, Kathryn L. BallDavid J. ArgyleBorivoj Vojtesek & Ted R. Hupp. (2021) Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody. Biochemical Journal 478:1, pages 99-120.
Crossref
Crossref
Osamu SAKAI, Shoji OGINO, Toshihiro TSUKUI, Masaya IGASE & Takuya MIZUNO. (2021) Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells. Journal of Veterinary Medical Science 83:10, pages 1495-1499.
Crossref
Crossref
Heng L. Tham, Keith E. Linder & Thierry Olivry. (2020) Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review. BMC Veterinary Research 16:1.
Crossref
Crossref
Takuya Mizuno, Yukinari Kato, Mika K. Kaneko, Yusuke Sakai, Toshinori Shiga, Masahiro Kato, Toshihiro Tsukui, Hirofumi Takemoto, Akio Tokimasa, Kenji Baba, Yuki Nemoto, Osamu Sakai & Masaya Igase. (2020) Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Scientific Reports 10:1.
Crossref
Crossref
F. Aires-da-Silva, J. Dias, S. I. Aguiar, F. Marques, A. André, S. Gil & L. Tavares. 2020. Advances in Animal Health, Medicine and Production. Advances in Animal Health, Medicine and Production
436
459
.
Yoseop Kim, Soo-Hyeon Lee, Cheol-Jung Kim, Je-Jung Lee, Dohyeon Yu, Soomin Ahn, Dong-Jun Shin & Sang-Ki Kim. (2019) Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells. BMC Veterinary Research 15:1.
Crossref
Crossref
Joana N.R. Dias, Mariana Lopes, Conceição Peleteiro, Gonçalo Vicente, Telmo Nunes, Luísa Mateus, Frederico Aires-da-Silva, Luís Tavares & Solange Gil. (2019) Canine multicentric lymphoma exhibits systemic and intratumoral cytokine dysregulation. Veterinary Immunology and Immunopathology 218, pages 109940.
Crossref
Crossref
Marta Lisowska, Magdalena Milczarek, Jarosław Ciekot, Justyna Kutkowska, Wojciech Hildebrand, Andrzej Rapak & Arkadiusz Miazek. (2019) An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma. Cancers 11:10, pages 1438.
Crossref
Crossref
Philip J. Bergman. (2019) Cancer Immunotherapies. Veterinary Clinics of North America: Small Animal Practice 49:5, pages 881-902.
Crossref
Crossref
Trenton S. Ewing, Jason B. Pieper & Adam W. Stern. (2019)
Prevalence of CD20
+
cutaneous epitheliotropic T-cell lymphoma in dogs: a retrospective analysis of 24 cases (2011-2018) in the USA
. Veterinary Dermatology 30:1, pages 51-e14.
Crossref
Crossref
David M. Vail, Douglas H. Thamm & Julias M. Liptak. 2019. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology
688
772
.
Marta Lisowska, Aleksandra Pawlak, Justyna Kutkowska, Wojciech Hildebrand, Maciej Ugorski, Andrzej Rapak & Arkadiusz Miazek. (2018) Development of novel monoclonal antibodies to dog leukocyte antigen DR displaying direct and immune-mediated cytotoxicity toward canine lymphoma cell lines. Hematological Oncology 36:3, pages 554-560.
Crossref
Crossref
Philip J. Bergman. (2018) Veterinary Oncology Immunotherapies. Veterinary Clinics of North America: Small Animal Practice 48:2, pages 257-277.
Crossref
Crossref
A. Pawlak, E. Ziolo, J. Kutkowska, A. Blazejczyk, J. Wietrzyk, A. Krupa, W. Hildebrand, P. Dziegiel, S. Dzimira, B. Obminska-Mrukowicz, L. Strzadala & A. Rapak. (2017) A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics. Veterinary and Comparative Oncology 15:4, pages 1218-1231.
Crossref
Crossref
Dane A. Hayes, Dale A. Kunde, Robyn L. Taylor, Stephen B. Pyecroft, Sukhwinder Singh Sohal & Elizabeth T. Snow. (2017) ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1). PLOS ONE 12:6, pages e0177919.
Crossref
Crossref
S. Sisó, P. Marco-Salazar, P. F. Moore, B. K. Sturges, W. Vernau, E. R. Wisner, A. W. Bollen, P. J. Dickinson & R. J. Higgins. (2016) Canine Nervous System Lymphoma Subtypes Display Characteristic Neuroanatomical Patterns. Veterinary Pathology 54:1, pages 53-60.
Crossref
Crossref
Jiwon S. Park, Sita S. Withers, Jaime F. Modiano, Michael S. Kent, Mingyi Chen, Jesus I. Luna, William T. N. Culp, Ellen E. Sparger, Robert B. Rebhun, Arta M. Monjazeb, William J. Murphy & Robert J. Canter. (2016) Canine cancer immunotherapy studies: linking mouse and human. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Kipp Weiskopf, Katie L. Anderson, Daisuke Ito, Peter J. Schnorr, Hirotaka Tomiyasu, Aaron M. Ring, Kristin Bloink, Jem Efe, Sarah Rue, David Lowery, Amira Barkal, Susan Prohaska, Kelly M. McKenna, Ingrid Cornax, Timothy D. O'Brien, M. Gerard O'Sullivan, Irving L. Weissman & Jaime F. Modiano. (2016) Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20. Cancer Immunology Research 4:12, pages 1072-1087.
Crossref
Crossref
Breno C.B. Beirão, Teresa Raposo, Saurabh Jain, Ted Hupp & David J. Argyle. (2016) Challenges and opportunities for monoclonal antibody therapy in veterinary oncology. The Veterinary Journal 218, pages 40-50.
Crossref
Crossref
M Kazim Panjwani, Jenessa B Smith, Keith Schutsky, Josephine Gnanandarajah, Colleen M O'Connor, Daniel J PowellJrJr & Nicola J Mason. (2016) Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma. Molecular Therapy 24:9, pages 1602-1614.
Crossref
Crossref
Masahiko Sato, Jumpei Yamazaki, Yuko Goto-Koshino, Asuka Setoguchi, Masashi Takahashi, Kenji Baba, Yasuhito Fujino, Koichi Ohno & Hajime Tsujimoto. (2016) Minimal residual disease in canine lymphoma: An objective marker to assess tumour cell burden in remission. The Veterinary Journal 215, pages 38-42.
Crossref
Crossref
James W Swann & Oliver A Garden. (2016) Novel immunotherapies for immune-mediated haemolytic anaemia in dogs and people. The Veterinary Journal 207, pages 13-19.
Crossref
Crossref
Dominique Tierny, François Serres, Zacharie Segaoula, Ingrid Bemelmans, Emmanuel Bouchaert, Aurélie Pétain, Viviane Brel, Stéphane Couffin, Thierry Marchal, Laurent Nguyen, Xavier Thuru, Pierre Ferré, Nicolas Guilbaud & Bruno Gomes. (2015) Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma. Clinical Cancer Research 21:23, pages 5314-5323.
Crossref
Crossref
Katie Anderson & Jaime Modiano. (2015) Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure. Veterinary Sciences 2:4, pages 363-387.
Crossref
Crossref
Daisuke Ito, Michael Childress, Nicola Mason, Amber Winter, Timothy O’Brien, Michael Henson, Antonella Borgatti, Mitzi Lewellen, Erika Krick, Jane Stewart, Sarah Lahrman, Bartek Rajwa, Milcah C Scott, Davis Seelig, Joseph Koopmeiners, Stephan Ruetz & Jaime Modiano. (2017) A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Research 4, pages 42.
Crossref
Crossref
Daisuke Ito, Michael Childress, Nicola Mason, Amber Winter, Timothy O’Brien, Michael Henson, Antonella Borgatti, Mitzi Lewellen, Erika Krick, Jane Stewart, Sarah Lahrman, Bartek Rajwa, Milcah C Scott, Davis Seelig, Joseph Koopmeiners, Stephan Ruetz & Jaime Modiano. (2017) A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Research 4, pages 42.
Crossref
Crossref
Daisuke Ito, Michael Childress, Nicola Mason, Amber Winter, Timothy O’Brien, Michael Henson, Antonella Borgatti, Mitzi Lewellen, Erika Krick, Jane Stewart, Sarah Lahrman, James Leary, Davis Seelig, Joseph Koopmeiners, Stephan Ruetz & Jaime Modiano. (2015) A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Research 4, pages 42.
Crossref
Crossref